The efficacy of recombinant thrombomodulin for post transplant coagulopathy in childre
Not Applicable
- Conditions
- children with coagulopathy after hematopoietic stem cell transplantation
- Registration Number
- JPRN-UMIN000005117
- Lead Sponsor
- Yokohama City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) The Patients with bleeding in brain, lung, or intestine. 2) Past history of allergy for recombinant thrombomodulin 3) Patients who refused to participate in the study 4) Other reasons by which physicians decide not to be eligible for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the safety of recombinant thrombomodulin for children with coagulopathy after hematopoietic stem cell transplantation
- Secondary Outcome Measures
Name Time Method To evaluate the rate to develop microangiopathy after hematopoietic stem cell transplantation